Sumeet Vyas, Ekta Kaul welcome baby boyThe couple have named their newborn Ved.
04 Jun, 2020, 11.49 AM IST
Lokpal: Myth to conception to birth to operational realityConsistency remained only PM Modi’s virtue. He had resolutely and obstinately blocked a Lokayukta during his entire 2003-13 chief ministers...
19 Mar, 2019, 08.22 AM IST
Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
23 Sep, 2015, 07.21 PM IST
- Dharma as armour
That might explain the proverbial saying, Vyasocchistasam Jagad sarvam; that aeons ago, the sage Vyasa vetted his lips on every screenplay ...
03 May, 2013, 04.00 AM IST
- Dishman to exit SEZ biz, raise Rs 600 crore
Dishman Pharma scraps its SEZ project. Will sell its SEZ land near Ahmedabad to off its bank debt.
03 Jul, 2012, 04.55 PM IST
- Pharma firms augment Vitamin D3 capacities to meet growing demand
Less exposure to sunlight and changing food habits have found to be causing deficiency of Vitamin D3 and active pharmaceutical ingredient-m...
19 Jun, 2012, 02.23 PM IST
- Dishman revives engineering SEZ project, land acquisition to complete in one year
Ahmedabad-based Dishman group will acquire 100 hectares land and revive its engineering SEZ project, it scrapped two years ago.
30 Dec, 2011, 04.39 PM IST
- Incurred loss on account of Rs 16 crore forex losses in Q2: JR Vyas, Dishman Pharma
JR Vyas, MD, Dishman Pharma in an interview with ET Now talks about the loss that the company incurred in the second quarter.
11 Nov, 2011, 04.54 PM IST
- We see order book of Rs 1,050 by year-end: JR Vyas, MD, Dishman Pharma
JR Vyas, MD, Dishman Pharma, says that the company has orders in hand worth Rs 800 crore and expects an order book of Rs 1,050 by year-end.
01 Sep, 2010, 01.23 PM IST
- Dishman Pharma's SEZ to take off after 4-year delay
SEZ project of listed entity Dishman Pharmaceuticals & Chemicals to finally take off after a delay of over four years.
03 Apr, 2010, 02.46 AM IST
- Dishman to chase high-potency therapies
Dishman Pharmaceuticals Ltd, will now focus on the high-potency therapies like steroids, hormones, isotopes and cytotoxics.
28 Jan, 2010, 11.02 PM IST
- Dishman scraps engg SEZ, merges it with pharma project
The Rs 1,000-crore Dishman Pharmaceuticals & Chemicals Ltd, a contract research and manufacturing services (CRAMS) major, has scrapped its ...
01 Aug, 2009, 02.06 PM IST
- Dishman plans JVs with up to 10 foreign cos
Dishman Pharmaceuticals is planning joint ventures with 8-10 global mid-sized companies through joint ventures.
26 Dec, 2008, 12.09 AM IST
- Dishman plans bond issue as IFC talks fail
Pharma company Dishman Pharmaceuticals’ talks with the World Bank’s financial arm International Finance Corporation (IFC) to raise $30 mill...
19 Dec, 2008, 12.25 AM IST
- Dishman earmarks $50 mn for buys in US, Europe
Drug firm Dishman Pharmaceutical and Chemicals on Friday said it has earmarked an amount of $50 million to acquire US and European companie...
13 Oct, 2007, 02.14 AM IST
- Carbogen buyout to help Dishman boost US sales
Revenues from the US will see a quantum jump to over 40% of consolidated sales of Dishman Pharmaceuticals & Chemicals this year from around...
26 Dec, 2006, 02.15 AM IST
- Solvay's sourcing from Dishman to cross Rs 100 cr
Solvay Pharmaceuticals BV the $11bn pharmaceutical major has consistently increased its sourcing from the Ahmedabad-based Dishman Pharmaceu...
23 Oct, 2006, 12.29 AM IST